ARCHIVES

ODAC To Review Taxol Nov. 16; NCI, Bristol to Discuss Pricing

This article is from The Cancer Letter archive.

Vol. 18 No. 41 | October 23, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief: Durant To Leave Alabama, Will Become President, Chief Executive Officer At Fox Chase Cancer Center

September 17, 1982

Scientific Misconduct: HHS To Change Role Of ORI In Response To Council Report

December 3, 1999

“Inoperable” Prostate Cancer May Be Operable, Curable

April 29, 2005

Patients Report Clinical Trials Not Offered By Physician

June 27, 2008

FASEB Urges Congress To Fund Stem Cell Research.

July 27, 2001

NCCS Begins Program To Help Develop Survivors’ Care Plan

February 27, 2009